Classical homocystinuria presenting with bilateral ectopia lentis and multisystem involvement in a pediatric patient: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20252809Keywords:
Pyridoxine, Optic atrophy, Marfan syndrome-like features, Intellectual disability, Cystathionine beta-synthase deficiency, Ectopia lentis, Fatty liver, Inborn errorsAbstract
Homocystinuria (HCU) is an uncommon inherited metabolic condition caused by a deficiency of the enzyme cystathionine beta-synthase (CBS), which disrupts the normal breakdown of methionine. It leads to elevated homocysteine levels and a wide spectrum of multisystem clinical manifestations. Early recognition and intervention are crucial to prevent irreversible complications. We report the case of a 10-year-old male, firstborn of non-consanguineous parents, presenting with progressive visual impairment, generalized weakness, bilateral knee swelling and increased urinary frequency. Family history revealed early vision loss in a younger sibling. Ocular examination showed bilateral ectopia lentis and optic atrophy. Skeletal features were suggestive of a Marfanoid habitus. Cognitive evaluation indicated borderline intellectual functioning. Laboratory investigations revealed macrocytic anemia, mild liver enzyme elevation and a significantly elevated serum homocysteine level (50 µmol/l), confirming the diagnosis of classical homocystinuria. High-dose pyridoxine and folate supplementation were initiated.
This case highlights the classical phenotype of homocystinuria, including ocular, skeletal, hematologic, hepatic and cognitive involvement. Despite the treatable nature of HCU, diagnostic delays remain common, especially in resource-limited settings. Early diagnosis through clinical suspicion and biochemical testing, along with multidisciplinary management, is essential to reduce morbidity. Homocystinuria should be considered in pediatric patients presenting with ectopia lentis, skeletal disproportions and developmental delay. Timely diagnosis and appropriate treatment can significantly improve outcomes and prevent life-threatening complications.
Metrics
References
Gerrard A, Dawson C. Homocystinuria diagnosis and management: it is not all classical. J Clin Pathol. 2022;75(11):744-50. DOI: https://doi.org/10.1136/jcp-2021-208029
Alkaissi H, McFarlane SI. Hyperhomocysteinemia and accelerated aging: the pathogenic role of increased homocysteine in atherosclerosis, osteoporosis and neurodegeneration. Cureus. 2023;21;15(7):746. DOI: https://doi.org/10.7759/cureus.42259
Naeem B, Nasim J, Irfan M, Ayesha H. Clinical diversity in pediatric homocystinuria: a case series of siblings. Medical Reports. 2023;2:100019. DOI: https://doi.org/10.1016/j.hmedic.2023.100019
Rahman M, Sharma M, Aggarwal P, Singla S, Jain N. Homocystinuria and ocular complications-A review. Indian J Ophthalmol. 2022;70(7):2272-8. DOI: https://doi.org/10.4103/ijo.IJO_309_22
Morrison T, Bösch F, Landolt MA, Kožich V, Huemer M, Morris AA. Homocystinuria patient and caregiver survey: experiences of diagnosis and patient satisfaction. Orphanet J Rare Dis. 2021;16:1-2. DOI: https://doi.org/10.1186/s13023-021-01764-x
Rehman T, Agrawal R, Ahamed F, Das S, Mitra S, Kumar D, et al. Optimal dose and duration of iron supplementation for treating iron deficiency anaemia in children and adolescents: A systematic review and meta-analysis. Plos one. 2025;20(2):319068. DOI: https://doi.org/10.1371/journal.pone.0319068
Centers for Disease Control and Prevention 2. Centers for disease control and prevention. Centers for Disease Control and Prevention. 2000.
Roopesh BN. Advanced scoring and interpretation of vineland social maturity scale: procedure to obtain 'impairment adjusted social quotient'. Indian J Mental Health. 2022;12:1-6. DOI: https://doi.org/10.30877/IJMH.9.1.2022.13-24
Alzwaihri AS, Almasoudi EA, Hadrawi MT, Danish EY, Alasmari FF, Ahmed HA. Incidence and risk factors of ocular complications among patients with homocystinuria in Saudi Arabia: a cross-sectional study. Annals of Med Surg. 2025;87(5):2602-7. DOI: https://doi.org/10.1097/MS9.0000000000003001
González-Lamuño D, Arrieta-Blanco FJ, Fuentes ED, Forga-Visa MT, Morales-Conejo M, Peña-Quintana L, et al. Hyperhomocysteinemia in adult patients: a treatable metabolic condition. Nutrients. 2023;16(1):135. DOI: https://doi.org/10.3390/nu16010135
Luzzi S, Cherubini V, Falsetti L, Viticchi G, Silvestrini M, Toraldo A. Homocysteine, cognitive functions and degenerative dementias: State of the art. Biomedicines. 2022;10(11):2741. DOI: https://doi.org/10.3390/biomedicines10112741
Werge MP, McCann A, Galsgaard ED, Holst D, Bugge A, Albrechtsen NJ, et al. The role of the transsulfuration pathway in non-alcoholic fatty liver disease. J Clin Med. 20215;10(5):1081. DOI: https://doi.org/10.3390/jcm10051081
Ochoa-Ferraro A, Wanninayake S, Dawson C, Gerrard A, Preece MA, Geberhiwot T. A case series of cerebral venous thrombosis as the first manifestation of homocystinuria. European Stroke J. 2021;6(4):420-7. DOI: https://doi.org/10.1177/23969873211059479
Liu Y, Li Y, Wang R, Chen S, Sun N, Qi X. Development of a chemiluminescent immunoassay based on magnetic solid phase for quantification of homocysteine in human serum. BMC biotechnology. 2024;9;24(1):77. DOI: https://doi.org/10.1186/s12896-024-00903-z
Samarasinghe N, Mahaliyanage D, De Silva S, Jasinge E, Punyasiri N, Dilanthi HW. Association of selected genetic variants in CBS and MTHFR genes in a cohort of children with homocystinuria in Sri Lanka. J Genetic Engin Biotechnol. 2022;1;20(1):164. DOI: https://doi.org/10.1186/s43141-022-00449-7
Roberts AM. Nutrition Management of Homocystinuria and Cobalamin Disorders. InNutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University 2022: 211-224. DOI: https://doi.org/10.1007/978-3-030-94510-7_15
Stabouli S, Sommer A, Kraft S, Schweer K, Bethe D, Bertholet-Thomas A, et al. Addressing the psychosocial aspects of transition to adult care in patients with cystinosis. Pediatric Nephrol. 2024;39(10):2861-74. DOI: https://doi.org/10.1007/s00467-024-06345-1